Literature DB >> 25744719

MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes.

Anna A Shvedova1, Elena R Kisin2, Naveena Yanamala2, Alexey V Tkach2, Dmitriy W Gutkin3, Alexander Star4, Galina V Shurin3, Valerian E Kagan5, Michael R Shurin6.   

Abstract

During the last decades, changes have been observed in the frequency of different histologic subtypes of lung cancer, one of the most common causes of morbidity and mortality, with a declining proportion of squamous cell carcinomas and an increasing proportion of adenocarcinomas, particularly in developed countries. This suggests the emergence of new etiologic factors and mechanisms, including those defining the lung microenvironment, promoting tumor growth. Assuming that the lung is the main portal of entry for broadly used nanomaterials and their established proinflammatory propensities, we hypothesized that nanomaterials may contribute to changes facilitating tumor growth. Here, we report that an acute exposure to single-walled carbon nanotubes (SWCNT) induces recruitment and accumulation of lung-associated myeloid-derived suppressor cells (MDSC) and MDSC-derived production of TGFβ, resulting in upregulated tumor burden in the lung. The production of TGFβ by MDSC requires their interaction with both SWCNT and tumor cells. We conclude that pulmonary exposure to SWCNT favors the formation of a niche that supports ingrowth of lung carcinoma in vivo via activation of TGFβ production by SWCNT-attracted and -presensitized MDSC. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744719      PMCID: PMC4401633          DOI: 10.1158/0008-5472.CAN-14-2376

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.

Authors:  J Won; H Kim; E J Park; Y Hong; S J Kim; Y Yun
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

2.  Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.

Authors:  Y Hasegawa; S Takanashi; Y Kanehira; T Tsushima; T Imai; K Okumura
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

Review 3.  TGF-β signalling and its role in cancer progression and metastasis.

Authors:  Yvette Drabsch; Peter ten Dijke
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

4.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation.

Authors:  Chiu-Wing Lam; John T James; Richard McCluskey; Robert L Hunter
Journal:  Toxicol Sci       Date:  2003-09-26       Impact factor: 4.849

Review 5.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma.

Authors:  Ken Donaldson; Fiona A Murphy; Rodger Duffin; Craig A Poland
Journal:  Part Fibre Toxicol       Date:  2010-03-22       Impact factor: 9.400

6.  GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.

Authors:  Johanna K Morales; Maciej Kmieciak; Keith L Knutson; Harry D Bear; Masoud H Manjili
Journal:  Breast Cancer Res Treat       Date:  2009-11-08       Impact factor: 4.872

7.  Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

Authors:  Hequan Li; Yanmei Han; Qiuli Guo; Minggang Zhang; Xuetao Cao
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  DNA damage induced by multiwalled carbon nanotubes in mouse embryonic stem cells.

Authors:  Lin Zhu; Dong Wook Chang; Liming Dai; Yiling Hong
Journal:  Nano Lett       Date:  2007-11-29       Impact factor: 11.189

9.  Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.

Authors:  Lauren A Matise; Trenis D Palmer; William J Ashby; Abudi Nashabi; Anna Chytil; Mary Aakre; Michael W Pickup; Agnieszka E Gorska; Andries Zijlstra; Harold L Moses
Journal:  Breast Cancer Res       Date:  2012-07-02       Impact factor: 6.466

10.  Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

Authors:  Masaki Terabe; So Matsui; Jong-Myun Park; Mizuko Mamura; Nancy Noben-Trauth; Debra D Donaldson; Wanjun Chen; Sharon M Wahl; Steven Ledbetter; Bruce Pratt; John J Letterio; William E Paul; Jay A Berzofsky
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  26 in total

1.  Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.

Authors:  Peter L Stern
Journal:  Ther Adv Vaccines       Date:  2017-07-20

2.  Tumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironment.

Authors:  Lei Gong; Mauricio da Silva Caetano; Amber M Cumpian; Soudabeh Daliri; Alejandra Garza Flores; Seon Hee Chang; Cesar E Ochoa; Christopher M Evans; Zhentao Yu; Seyed Javad Moghaddam
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

3.  SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.

Authors:  Priscilla S Redd; Mohammed L Ibrahim; John D Klement; Sarah K Sharman; Amy V Paschall; Dafeng Yang; Asha Nayak-Kapoor; Kebin Liu
Journal:  Cancer Res       Date:  2017-04-05       Impact factor: 12.701

4.  A Mouse Model of Endometriosis with Nanoparticle Labeling for In Vivo Photoacoustic Imaging.

Authors:  Ryan M Marquardt; Md Nafiujjaman; Tae Hoon Kim; Seock-Jin Chung; Kay Hadrick; Taeho Kim; Jae-Wook Jeong
Journal:  Reprod Sci       Date:  2022-05-31       Impact factor: 2.924

5.  Carcinogenic Potential of High Aspect Ratio Carbon Nanomaterials.

Authors:  Sudjit Luanpitpong; Liying Wang; Donna C Davidson; Heimo Riedel; Yon Rojanasakul
Journal:  Environ Sci Nano       Date:  2016-04-06

6.  TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy.

Authors:  Padmini Jayaraman; Falguni Parikh; Jared M Newton; Aurelie Hanoteau; Charlotte Rivas; Rosemarie Krupar; Kimal Rajapakshe; Ravi Pathak; Kavin Kanthaswamy; Cassie MacLaren; Shixia Huang; Cristian Coarfa; Chad Spanos; Dean P Edwards; Robin Parihar; Andrew G Sikora
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

7.  Integrated Analysis of Dysregulated ncRNA and mRNA Expression Profiles in Humans Exposed to Carbon Nanotubes.

Authors:  Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Timur O Khailullin; M Eileen Birch; Liliya M Fatkhutdinova
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

Review 8.  Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity.

Authors:  Kristian M Hargadon
Journal:  J Clin Med       Date:  2016-08-31       Impact factor: 4.241

Review 9.  A Review on the Respiratory System Toxicity of Carbon Nanoparticles.

Authors:  Maricica Pacurari; Kristine Lowe; Paul B Tchounwou; Ramzi Kafoury
Journal:  Int J Environ Res Public Health       Date:  2016-03-15       Impact factor: 3.390

10.  Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells.

Authors:  François Huaux; Virginie d'Ursel de Bousies; Marie-Astrid Parent; Micaela Orsi; Francine Uwambayinema; Raynal Devosse; Saloua Ibouraadaten; Yousof Yakoub; Nadtha Panin; Mihaly Palmai-Pallag; Pierre van der Bruggen; Christian Bailly; Riccardo Marega; Etienne Marbaix; Dominique Lison
Journal:  Part Fibre Toxicol       Date:  2016-08-23       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.